logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Prostate cancer: which glucocorticoid regimen is best with abiraterone in mCRPC?

Randomized study reported mineralocorticoid adverse effects of 4 regimens.